methamphetamine use disorder (+ hiv): trials, trends and
TRANSCRIPT
![Page 1: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/1.jpg)
Methamphetamineusedisorder(+HIV):Trials,TrendsandTribulations
WHAT-IF?LearningCollaborativeSeptember11,2019
PaxtonBachMD,MSc,ABIM,FRCPCClinicalAssistantProfessorUBCDepartmentofMedicineVancouver,Canada
![Page 2: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/2.jpg)
• Background• Physiologyandhealtheffects• Epidemiology• Treatment
Outline
![Page 3: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/3.jpg)
• HigherratesofmethuseinpopulationsatriskforHIV– Upto20%ofMSMmayreportmethusewithinpast6mo1
• MethuseisassociatedwithanincreasedriskofcontractingHIV– Higherratesofriskybehaviours(highriskinjectionand/orsexualpractices)2
– Impaired/alteredimmunity?3
• MethuseisassociatedwithworseHIVoutcomes– DecreasedARTadherence,slowerratesofRNAsuppression,decreasedCD4counts,pooroverallhealthoutcomes3,4
1Shoptawetal.Addiction,2007.2Degenhardtetal.IntJDrugPolicy,2009.3Passaroetal.JNeuroimmunePharmacol,2015.4Fairbairnetal.AddictBehav,2011.
Whythefuss?
![Page 4: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/4.jpg)
HIVprevalenceamongMSMwhoprimarilyinjectedmethwasalmost50%higherthanamongMSMwhoprimarilyinjectedotherdrugs,andthisassociationwasmediatedbysexualrisk.
![Page 5: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/5.jpg)
Background
![Page 6: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/6.jpg)
Ephedrasinica
![Page 7: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/7.jpg)
Methamphetaminepowder- POorinsufflated
Methamphetaminebase-POorinjected
Crystalmethamphetamine-Smoked,insufflatedorinjected
Ice,crystal,glass,speed,meth,jib,side,gak,chalk,crank,tina,go,geek,tweak,amp,P2P,zip,shards,goofball*
Half-lifeforall3closeto~10hours!
Methamphetamine
![Page 8: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/8.jpg)
Narcolepsy,exhaustion,weight loss,schizophrenia,asthma,morphineaddiction,barbiturate intoxication, alcoholism, excessive anaesthesia administration,migraine, heart block, myasthenia gravis, myotonia, enuresis, dysmenorrhea,Meniere’sdisease,colic,headinjuries,infantilecerebralpalsy,codeineaddiction,tobaccosmoking,pediatricbehaviourissues,Parkinson’sdisease,epilepsy…
![Page 9: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/9.jpg)
Physiologyandeffects
![Page 10: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/10.jpg)
Pharmacology
![Page 11: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/11.jpg)
• Mania/paranoia/psychosis• Hypertension,agitation,sweating• Skin-picking/formication(delusionsofinsectsundertheskin)
• Abnormalmovement(choreoathetosis,ataxia)
• Miosis
Acuteintoxication
![Page 12: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/12.jpg)
*Societalharms:environmentalhazards/pollution,crime,violence.
Cardiac Infectious Hematologic Gastrointestinal
Chestpain HIV Necrotizingangiitis Acuteliverinjury
CAD Viralhepatitis Mesentericinfarction
Myocardialinfarction MSK Ischemiccolitis
Tachycardia Neurologic “Methmouth” Pancreatitis
Hypertension ICH Rhabdomyolysis
Dysrhythmias Ischemicstroke Traumas Pulmonary
DilatedCMO Seizure Osteomyelitis Pulmonaryedema
Aorticdissection Cognitiveimpairment Pulmonaryhypertension
Infectiveendocarditis Obstetrical
Dermatologic Fetalgrowthrestriction Renal
Genitourinary Picking/excoriations Prematuredelivery Myoglobulinuria
STIs Cellulitis Abruption Necrotizingangiitis
Abscesses
AdaptedfromVearrieretal.DisMon,2012.
Meth-associatedhealthcomplications
![Page 13: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/13.jpg)
Volkowetal.AmJPsychiatry,2001.
Neurotoxicity(dopamineneurons)
![Page 14: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/14.jpg)
Epidemiology
![Page 15: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/15.jpg)
UNODCWorldDrugReport,2019.
![Page 16: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/16.jpg)
SAMHSANationalSurveyonDrugUseandHealth,2016.
USNationalSurveyonDruguseandHealth:PrevalenceofIllicitDrugUse
![Page 17: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/17.jpg)
DEANationalClandestineLaboratoryRegistry,2004-2012.
MethamphetamineLabDistributionintheUS
![Page 18: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/18.jpg)
![Page 19: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/19.jpg)
UNODCWorldDrugReport,2019.
Psychostimulant-relatedoverdosedeathsinUS,1999-2017
![Page 20: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/20.jpg)
Treatment
![Page 21: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/21.jpg)
![Page 22: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/22.jpg)
StimulantUseDisorderTreatment
Pharmacologic
Anti-Depressants
Anti-Psychotics
AgonistTherapies
Non-pharmacologic
CBT(+/-MI)
ContingencyManagement
ModafinilMethylphenidate
DextroamphetamineBupropion
AripiprazoleRisperidone
SSRIsMirtazapine
Others:gabapentin,baclofen,vigabatrin,topiramate,ondansetron,naltrexone,ibudilast…
![Page 23: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/23.jpg)
StudyDrug EffectPsychostimulants(dexamphetamine,methylphenidate)
9RCTs:maydecreaseuse,craving,and/orseverityofaddiction?
Topiramate 2RCTs:maydecreaseuse,and/orseverity?
Mirtazapine 1RCT:maydecreaseuse?Bupropion 5RCTs:maydecreaseuse?Naltrexone 2RCTs:maydecreaseuseand/or
craving?Modafinil 3RCTs:maydecreaseuse?
AdaptedfromLeeetal.,DrugAlcDep.2018.
*Studieslimitedbyretention,adherence,primaryoutcomes.
Trialmedications
![Page 24: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/24.jpg)
TreatmentofStimulantUseDisorder:PsychosocialTreatments
1. Contingencymanagement2. Cognitivebehavioural
therapy3. Motivationalinterviewing4. Relapseprevention5. Psychodynamictherapy6. Combinationsprograms
• Overallsmalltomoderateeffects(dropoutratesaretypically>40%)
• Immediateeffectsnoted,long-termbenefitsformethusedisordernotclear
![Page 25: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/25.jpg)
TreatmentofStimulantUseDisorder:PsychosocialTreatmentsContingencyManagement
• Goalistoreducereinforcementprovidedbydrugusewhilesimultaneouslyincreasingreinforcementforhealthieractivities
• Appliescontingenciesintheformofreinforcementandconsequencesinordertoreducesubstanceuse
• Oftenusesavoucher-basedsystemtogivepossiblerewardsforstayingintreatmentorremainingdrug-free
• A2016systematicreviewfoundthatcontingencymanagementhelpedtodecreaseuseinadiversegroupofsubstanceusedisorders,withatreatmenteffectthatweakenedbutdidnotdisappearfollowingtreatmenttermination1 1Davisetal.PrevMed,2016.
![Page 26: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/26.jpg)
ClinicalresponsestoCMinPROPweresimilartoCMdeliveredindrugtreatmentprograms.[…]FurtherexpansionofprogramslikePROPcouldaddresstheincreasingneedsforacceptable,feasible,andcost-
effectivemethamphetaminetreatmentinthisgroupwithexceptionallyhighratesofHIV-infection.
![Page 27: Methamphetamine use disorder (+ HIV): Trials, Trends and](https://reader031.vdocuments.net/reader031/viewer/2022012518/61930196b655c10ab31ad003/html5/thumbnails/27.jpg)
Conclusions• Theprevalenceofmethamphetamineusecontinuestoriseanditisassociatedwithnumerousphysical,psychiatric,andsocialharms
• MethamphetamineuseisassociatedwithanincreasedriskofcontractingHIVandworseHIVtreatmentoutcomes
• Evidence-basedtreatmentsareavailableforstimulantusedisorder,psychosocialapproaches(esp.CM)remainthegoldstandardandcanbeimplementedinsettingswithhighratesofHIV